A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Clinical trial NCT06788639 · RECRUITING

Trial details

NCT number: NCT06788639
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2025-02-04
Primary completion: 2044-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.